Skip to main content
. 2018 Feb 25;32(6):1317–1326. doi: 10.1038/s41375-018-0075-3

Fig. 6.

Fig. 6

Depletion of infused 123b-33bcCAR T-cells following treatment with alemtuzumab. a Experimental schema to evaluate the effect of alemtuzumab administration after 123b-33bcCAR T-cells infusion into NGS mice. b Representation of 123b-33bcCAR T-cells persistence in peripheral blood 6 h later. Presence of 123b-33bcCAR T-cells was detected by flow cytometry. c Representation of persistence of infused 123b-33bcCAR T-cells in peripheral blood 24 h later. Presence of 123b-33bcCAR T-cells was detected by flow cytometry